MedTrace Logo

Using High Resolution Function Imaging To Detect Melanoma and Dysplastic Nevi

NCT01118832 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2019-02-08

No results posted yet for this study

Summary

A novel infrared imaging tool to aid in the clinical detection of atypical pigmented lesions and melanoma is developed. Goals include evaluation of the utility of high-resolution infrared scanning of cutaneous lesions in the diagnosis of pigmented lesions and the identification of high-risk lesions and melanomas.

Conditions

Sponsors & Collaborators

  • Johns Hopkins University

    collaborator OTHER

  • National Cancer Institute (NCI)

    collaborator NIH

  • Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

    lead OTHER

Principal Investigators

  • Cila Herman, Dr-Ing. · Johns Hopkins University

Eligibility

Min Age
10 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-09-22
Primary Completion
2010-06-29
Completion
2012-02-20

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01118832 on ClinicalTrials.gov